FORT MYERS, Fla. (AP) _ NeoGenomics Inc. (NEO) on Friday reported second-quarter net income of $75.9 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Fort Myers, Florida-based company said it had profit of 59 cents. Losses, adjusted for non-recurring gains, came to 1 cent per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.

The operator of cancer-focused testing laboratories posted revenue of $121.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $120.5 million.

NeoGenomics expects full-year results to range from a loss of 27 cents per share to a loss of 23 cents per share, with revenue in the range of $490 million to $510 million.

NeoGenomics shares have decreased 11% since the beginning of the year. The stock has climbed 18% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News